Jpmorgan Chase & CO Artivion, Inc. Put Options Transaction History
Jpmorgan Chase & CO
- $1.14 Trillion
- Q2 2024
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
Others Institutions Holding AORT
# of Institutions
163Shares Held
35.4MCall Options Held
21KPut Options Held
6.8K-
Black Rock Inc. New York, NY6.64MShares$178 Million0.0% of portfolio
-
Macquarie Group LTD Australia, C32.81MShares$75.2 Million0.08% of portfolio
-
Perceptive Advisors LLC New York, NY2.79MShares$74.7 Million2.07% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.77MShares$74.1 Million0.0% of portfolio
-
Morgan Stanley New York, NY2.36MShares$63.1 Million0.0% of portfolio
About ARTIVION, INC.
- Ticker AORT
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 40,316,100
- Market Cap $1.08B
- Description
- Artivion Inc. manufactures, processes, and distributes medical devices and implantable human tissues worldwide. The company offers BioGlue, a polymer consisting of bovine blood protein and an agent for cross-linking proteins for cardiac, vascular, neurologic, and pulmonary procedures; cardiac preservation services; PhotoFix, a bovine pericardial...